IRTC

IRTC

USD

iRhythm Technologies Inc. Common Stock

$181.100-1.580 (-0.865%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$182.680

Максимум

$185.040

Минимум

$177.740

Объем

0.37M

Фундаментальные показатели компании

Рыночная капитализация

5.8B

Отрасль

Медицинские приборы

Страна

United States

Статистические данные торговли

Средний объем

0.40M

Биржа

NMS

Валюта

USD

52-недельный диапазон

Минимум $71Текущая $181.100Максимум $212

Связанные новости

GlobeNewswire

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today

Просмотреть больше
iRhythm Technologies to Participate in Upcoming Investor Conferences
Analyst Upgrades

Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies with a Buy and raises the price target from $193 to $212.

Просмотреть больше
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212
Analyst Upgrades

Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies with a Buy and raises the price target from $205 to $242.

Просмотреть больше
Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242
Analyst Upgrades

JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240

JP Morgan analyst Allen Gong maintains iRhythm Technologies with a Overweight and raises the price target from $190 to $240.

Просмотреть больше
JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240
Analyst Upgrades

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets.

Просмотреть больше
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
Analyst Upgrades

Goldman Sachs Maintains Neutral on iRhythm Technologies, Raises Price Target to $202

Goldman Sachs analyst David Roman maintains iRhythm Technologies with a Neutral and raises the price target from $180 to $202.

Analyst Upgrades

Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $244

Needham analyst David Saxon maintains iRhythm Technologies with a Buy and raises the price target from $193 to $244.

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.